The Experience Matters. Let us show you why.
Contact us today.
Bart Cobert reviews the changes and updates happening with UK and EMA inspections.
Read MorePharmacovigilance expert Bart Cobert examines the issues associated with language translation in PV and drug safety.
Read MoreBart Cobert highlights the ongoing saga with EMA and Brexit. In this post, he elaborates on the lack of a current Brexit deal between the EU and the UK.
Read MoreAnother update from Bart Cobert regarding the ongoing Brexit saga.
Read MoreThe Brexit saga continues. Here Bart Cobert highlights new Brexit developments with regard to the EMA.
Read MoreBart Cobert reviews the key requirements for the US-EU Privacy Shield, including implications for US Firms, Pharma Companies, and Drug Safety & Pharmacovigilance
Read MoreBart Cobert reviews the HIPAA and current EU data privacy system and their impacts on drug safety and PV.
Read MoreIt’s decided: the EMA is moving to Amsterdam, The Netherlands by March 30, 2019. Less than two years away. Bart Cobert highlights the PV/Drug Safety concerns of the EMA move.
Read MoreThe EU is in turmoil as the Brexit EMA relocation continues to percolate, particularly behind closed doors. Also EU inspections are being discussed.
Read MoreAs an industry leader in business process outsourcing, HCL Technologies delivers global, multi-channel engagement solutions. The Experience Matters. Let us show you why.
Contact UsPlease note: we are currently updating our website which will be live shortly.